SFJ Pharma Ltd. II
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients (NCT01599754) | SFJ Pharma Ltd. II | 2012-04-01 |
Track SFJ Pharma Ltd. II automatically
Every clearance here is in the API, with alerts when new ones post.